Streamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master Trial is a research paper published in Therapeutic Innovation & Regulatory Science (2021). On theSindex it has a DataRank of 0.353. It has been cited 5 times, with 5 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0846
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 5 citers.
NIH (US)/NCI (US) Cancer Center Support Grant
Grant: P30 CA008748
National Cancer Institute
Grant: R35 CA198183
National Cancer Institute
Grant: R35 CA197594
National Institutes of Health
Grant: 5R35CA197734-06
Targeted Therapy for Leukemia
National Institutes of Health
Grant: 1R03DC001038-01
MODEL FOR DEVELOPMENT OF CEREBRAL ASYMMETRY
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R35CA197594-09
Synergistic role of signaling and epigenetics in leukemic transformation
FWCI
0.08
Citation Percentile
0.3%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals